| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalization | 40 | 2025 | 1403 | 4.880 |
Why?
|
| Heart Failure | 20 | 2026 | 965 | 4.780 |
Why?
|
| Cardiac Rehabilitation | 9 | 2026 | 76 | 3.060 |
Why?
|
| Hospitals | 16 | 2023 | 398 | 2.690 |
Why?
|
| Hospital Mortality | 22 | 2024 | 879 | 2.540 |
Why?
|
| Medicare | 12 | 2026 | 629 | 2.540 |
Why?
|
| Physicians | 10 | 2022 | 486 | 2.520 |
Why?
|
| Sepsis | 14 | 2021 | 302 | 2.430 |
Why?
|
| Respiration, Artificial | 13 | 2021 | 300 | 2.280 |
Why?
|
| Accountable Care Organizations | 3 | 2026 | 76 | 2.190 |
Why?
|
| Patient Satisfaction | 8 | 2019 | 442 | 1.670 |
Why?
|
| Humans | 140 | 2026 | 65635 | 1.640 |
Why?
|
| Critical Care | 6 | 2018 | 416 | 1.630 |
Why?
|
| Quality of Health Care | 12 | 2017 | 533 | 1.630 |
Why?
|
| United States | 65 | 2026 | 8166 | 1.590 |
Why?
|
| Aged | 69 | 2026 | 15087 | 1.530 |
Why?
|
| Aged, 80 and over | 39 | 2025 | 5656 | 1.530 |
Why?
|
| Pneumonia | 14 | 2022 | 295 | 1.510 |
Why?
|
| Female | 94 | 2026 | 34298 | 1.430 |
Why?
|
| Male | 86 | 2026 | 31285 | 1.430 |
Why?
|
| Internet | 8 | 2019 | 472 | 1.410 |
Why?
|
| Retrospective Studies | 53 | 2026 | 6948 | 1.370 |
Why?
|
| Palliative Care | 3 | 2025 | 250 | 1.360 |
Why?
|
| Health Services Accessibility | 8 | 2022 | 603 | 1.340 |
Why?
|
| Quality Indicators, Health Care | 8 | 2018 | 348 | 1.220 |
Why?
|
| Middle Aged | 57 | 2026 | 18434 | 1.210 |
Why?
|
| Neoplasms | 6 | 2023 | 1376 | 1.150 |
Why?
|
| Length of Stay | 19 | 2024 | 828 | 1.120 |
Why?
|
| Patient Compliance | 3 | 2026 | 370 | 1.120 |
Why?
|
| Intensive Care Units | 6 | 2018 | 436 | 1.070 |
Why?
|
| Critical Illness | 5 | 2018 | 340 | 1.030 |
Why?
|
| Attitude of Health Personnel | 6 | 2021 | 631 | 1.030 |
Why?
|
| Cardiotonic Agents | 2 | 2025 | 54 | 0.920 |
Why?
|
| Patient Participation | 3 | 2026 | 239 | 0.920 |
Why?
|
| Patient Readmission | 9 | 2023 | 452 | 0.890 |
Why?
|
| Hospital Costs | 7 | 2016 | 126 | 0.890 |
Why?
|
| Quality Improvement | 6 | 2024 | 468 | 0.880 |
Why?
|
| International Classification of Diseases | 3 | 2017 | 136 | 0.880 |
Why?
|
| Patient Discharge | 6 | 2020 | 521 | 0.870 |
Why?
|
| Inpatients | 9 | 2025 | 322 | 0.830 |
Why?
|
| Malnutrition | 1 | 2024 | 41 | 0.820 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2019 | 505 | 0.810 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 10 | 2023 | 707 | 0.800 |
Why?
|
| Patient Care | 2 | 2015 | 79 | 0.780 |
Why?
|
| Cohort Studies | 23 | 2021 | 2639 | 0.770 |
Why?
|
| Social Media | 2 | 2015 | 129 | 0.770 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 303 | 0.760 |
Why?
|
| Cardiovascular System | 1 | 2023 | 41 | 0.760 |
Why?
|
| Spinal Cord Injuries | 1 | 2023 | 55 | 0.750 |
Why?
|
| Heart Diseases | 2 | 2022 | 223 | 0.740 |
Why?
|
| Healthcare Disparities | 5 | 2022 | 409 | 0.720 |
Why?
|
| Dementia | 2 | 2016 | 285 | 0.690 |
Why?
|
| Abortion, Induced | 1 | 2022 | 29 | 0.690 |
Why?
|
| Heart Transplantation | 1 | 2023 | 180 | 0.690 |
Why?
|
| Physician-Patient Relations | 5 | 2022 | 429 | 0.690 |
Why?
|
| Treatment Outcome | 21 | 2025 | 5818 | 0.650 |
Why?
|
| Databases, Factual | 14 | 2018 | 888 | 0.640 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 26 | 0.640 |
Why?
|
| Adult | 37 | 2025 | 17508 | 0.640 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 48 | 0.630 |
Why?
|
| Racism | 1 | 2022 | 93 | 0.630 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 872 | 0.620 |
Why?
|
| Endocarditis | 2 | 2017 | 27 | 0.610 |
Why?
|
| Cross Infection | 5 | 2017 | 170 | 0.610 |
Why?
|
| Rheumatoid Factor | 1 | 2019 | 13 | 0.610 |
Why?
|
| Empathy | 1 | 2020 | 69 | 0.600 |
Why?
|
| Patient Care Team | 2 | 2020 | 337 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 9 | 2022 | 807 | 0.590 |
Why?
|
| Respiratory Insufficiency | 5 | 2024 | 154 | 0.590 |
Why?
|
| Risk Assessment | 11 | 2021 | 2113 | 0.580 |
Why?
|
| Potassium | 1 | 2019 | 98 | 0.580 |
Why?
|
| Social Networking | 1 | 2019 | 23 | 0.580 |
Why?
|
| Cross-Sectional Studies | 14 | 2021 | 2730 | 0.580 |
Why?
|
| Autoantibodies | 1 | 2019 | 185 | 0.570 |
Why?
|
| Surveys and Questionnaires | 7 | 2019 | 2788 | 0.560 |
Why?
|
| Risk Factors | 16 | 2023 | 5466 | 0.560 |
Why?
|
| Communication | 3 | 2022 | 606 | 0.550 |
Why?
|
| Liver Cirrhosis | 3 | 2014 | 184 | 0.550 |
Why?
|
| Betacoronavirus | 1 | 2020 | 181 | 0.550 |
Why?
|
| Burnout, Professional | 1 | 2020 | 145 | 0.530 |
Why?
|
| Logistic Models | 9 | 2021 | 1273 | 0.530 |
Why?
|
| Hypertension | 2 | 2020 | 616 | 0.520 |
Why?
|
| Pneumonia, Bacterial | 5 | 2017 | 91 | 0.520 |
Why?
|
| Noninvasive Ventilation | 5 | 2021 | 68 | 0.520 |
Why?
|
| Patients | 2 | 2022 | 117 | 0.510 |
Why?
|
| Residence Characteristics | 4 | 2017 | 230 | 0.510 |
Why?
|
| Research Report | 1 | 2017 | 26 | 0.510 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.510 |
Why?
|
| Patient Admission | 5 | 2017 | 200 | 0.510 |
Why?
|
| Terminal Care | 1 | 2018 | 121 | 0.510 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 219 | 0.510 |
Why?
|
| Information Services | 1 | 2017 | 35 | 0.500 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 111 | 0.490 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 264 | 0.490 |
Why?
|
| Interviews as Topic | 3 | 2026 | 535 | 0.490 |
Why?
|
| Guideline Adherence | 3 | 2017 | 310 | 0.480 |
Why?
|
| Prenatal Care | 3 | 2020 | 173 | 0.470 |
Why?
|
| Community-Acquired Infections | 6 | 2022 | 95 | 0.460 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 133 | 0.460 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 346 | 0.460 |
Why?
|
| Endocarditis, Bacterial | 1 | 2016 | 36 | 0.460 |
Why?
|
| Mobility Limitation | 1 | 2015 | 49 | 0.450 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 170 | 0.450 |
Why?
|
| Liver Diseases | 1 | 2017 | 157 | 0.450 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2012 | 62 | 0.450 |
Why?
|
| Medicine in Literature | 1 | 2015 | 1 | 0.450 |
Why?
|
| Public Policy | 1 | 2015 | 38 | 0.450 |
Why?
|
| Health Services for Persons with Disabilities | 1 | 2015 | 2 | 0.440 |
Why?
|
| Mortality | 1 | 2016 | 162 | 0.440 |
Why?
|
| Quality of Life | 3 | 2023 | 1264 | 0.430 |
Why?
|
| Paracentesis | 1 | 2014 | 12 | 0.430 |
Why?
|
| Ascites | 1 | 2014 | 22 | 0.430 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 196 | 0.420 |
Why?
|
| Minority Groups | 3 | 2025 | 143 | 0.420 |
Why?
|
| Comorbidity | 10 | 2017 | 1120 | 0.400 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 253 | 0.390 |
Why?
|
| Time Factors | 8 | 2021 | 3777 | 0.390 |
Why?
|
| Clostridium Infections | 1 | 2014 | 49 | 0.390 |
Why?
|
| Relative Value Scales | 1 | 2013 | 14 | 0.390 |
Why?
|
| Prognosis | 5 | 2016 | 1791 | 0.390 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 67 | 0.390 |
Why?
|
| Age Factors | 6 | 2016 | 1592 | 0.380 |
Why?
|
| Hospital Administration | 2 | 2013 | 43 | 0.370 |
Why?
|
| Specialization | 1 | 2013 | 82 | 0.370 |
Why?
|
| Adolescent | 19 | 2026 | 6349 | 0.370 |
Why?
|
| Costs and Cost Analysis | 3 | 2023 | 106 | 0.370 |
Why?
|
| Echocardiography | 3 | 2023 | 513 | 0.360 |
Why?
|
| Shock, Septic | 2 | 2015 | 89 | 0.360 |
Why?
|
| Qualitative Research | 5 | 2026 | 762 | 0.350 |
Why?
|
| Social Responsibility | 1 | 2011 | 12 | 0.330 |
Why?
|
| Liability, Legal | 1 | 2011 | 17 | 0.330 |
Why?
|
| Privacy | 1 | 2011 | 10 | 0.330 |
Why?
|
| Cost of Illness | 1 | 2012 | 169 | 0.330 |
Why?
|
| Social Environment | 1 | 2011 | 93 | 0.320 |
Why?
|
| Disclosure | 1 | 2010 | 57 | 0.320 |
Why?
|
| Postoperative Complications | 4 | 2024 | 1335 | 0.310 |
Why?
|
| Patient Transfer | 2 | 2024 | 93 | 0.300 |
Why?
|
| Information Dissemination | 1 | 2010 | 114 | 0.300 |
Why?
|
| Fee-for-Service Plans | 3 | 2025 | 71 | 0.290 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1567 | 0.290 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 1715 | 0.290 |
Why?
|
| Waiting Lists | 2 | 2023 | 55 | 0.280 |
Why?
|
| Pregnancy | 8 | 2022 | 2392 | 0.280 |
Why?
|
| Young Adult | 13 | 2017 | 4855 | 0.280 |
Why?
|
| Intubation, Intratracheal | 2 | 2021 | 197 | 0.280 |
Why?
|
| Pediatrics | 3 | 2017 | 264 | 0.280 |
Why?
|
| Health Care Surveys | 5 | 2017 | 288 | 0.270 |
Why?
|
| Coronary Artery Bypass | 3 | 2019 | 292 | 0.270 |
Why?
|
| Referral and Consultation | 2 | 2026 | 445 | 0.260 |
Why?
|
| Social Support | 1 | 2010 | 394 | 0.250 |
Why?
|
| Coronary Disease | 2 | 2018 | 246 | 0.250 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 921 | 0.250 |
Why?
|
| California | 2 | 2017 | 178 | 0.240 |
Why?
|
| Exercise Therapy | 3 | 2021 | 102 | 0.240 |
Why?
|
| Choice Behavior | 2 | 2017 | 86 | 0.240 |
Why?
|
| Poverty | 4 | 2017 | 307 | 0.240 |
Why?
|
| Health Resources | 3 | 2019 | 92 | 0.230 |
Why?
|
| Economics, Hospital | 2 | 2019 | 15 | 0.230 |
Why?
|
| Pandemics | 2 | 2021 | 691 | 0.230 |
Why?
|
| Personnel, Hospital | 1 | 2025 | 43 | 0.220 |
Why?
|
| Home Care Services | 1 | 2026 | 105 | 0.220 |
Why?
|
| Hospital Administrators | 2 | 2015 | 10 | 0.220 |
Why?
|
| Access to Information | 2 | 2015 | 31 | 0.220 |
Why?
|
| Research Design | 3 | 2019 | 590 | 0.220 |
Why?
|
| Sex Factors | 3 | 2012 | 995 | 0.210 |
Why?
|
| Health Expenditures | 2 | 2019 | 122 | 0.210 |
Why?
|
| Patient Navigation | 2 | 2016 | 37 | 0.210 |
Why?
|
| Medical Staff, Hospital | 2 | 2015 | 60 | 0.210 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2017 | 171 | 0.210 |
Why?
|
| Soft Tissue Infections | 2 | 2015 | 48 | 0.210 |
Why?
|
| Attitude | 2 | 2015 | 102 | 0.210 |
Why?
|
| Hospice Care | 1 | 2025 | 75 | 0.210 |
Why?
|
| Patient Safety | 2 | 2026 | 281 | 0.210 |
Why?
|
| Hospitals, Rural | 2 | 2015 | 17 | 0.210 |
Why?
|
| Needs Assessment | 1 | 2025 | 202 | 0.210 |
Why?
|
| Acute Disease | 5 | 2019 | 663 | 0.210 |
Why?
|
| Hospitals, Urban | 2 | 2015 | 44 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 770 | 0.210 |
Why?
|
| Medical Errors | 1 | 2026 | 202 | 0.210 |
Why?
|
| Odds Ratio | 2 | 2016 | 757 | 0.210 |
Why?
|
| Urinary Tract Infections | 2 | 2015 | 97 | 0.200 |
Why?
|
| Emergency Service, Hospital | 5 | 2020 | 1163 | 0.200 |
Why?
|
| Hospitals, Teaching | 2 | 2015 | 105 | 0.200 |
Why?
|
| Biomarkers | 2 | 2019 | 1487 | 0.200 |
Why?
|
| Asthma | 3 | 2021 | 485 | 0.200 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 56 | 0.190 |
Why?
|
| End Stage Liver Disease | 1 | 2023 | 32 | 0.190 |
Why?
|
| Education, Medical | 1 | 2025 | 183 | 0.190 |
Why?
|
| Smoking Cessation | 2 | 2018 | 553 | 0.190 |
Why?
|
| Hospital Bed Capacity | 2 | 2013 | 27 | 0.190 |
Why?
|
| Selection Bias | 1 | 2022 | 23 | 0.180 |
Why?
|
| State Medicine | 2 | 2013 | 12 | 0.180 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 931 | 0.180 |
Why?
|
| Disease Progression | 5 | 2019 | 1225 | 0.180 |
Why?
|
| Infant | 8 | 2026 | 1711 | 0.180 |
Why?
|
| Governing Board | 1 | 2021 | 3 | 0.180 |
Why?
|
| Insurance Claim Review | 2 | 2012 | 76 | 0.180 |
Why?
|
| Exercise | 4 | 2021 | 970 | 0.170 |
Why?
|
| Students, Medical | 1 | 2025 | 268 | 0.170 |
Why?
|
| Prevalence | 2 | 2024 | 1453 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2018 | 710 | 0.170 |
Why?
|
| Electronic Health Records | 4 | 2021 | 398 | 0.170 |
Why?
|
| Survival Analysis | 3 | 2020 | 579 | 0.170 |
Why?
|
| Febrile Neutropenia | 1 | 2021 | 6 | 0.170 |
Why?
|
| Trust | 1 | 2022 | 81 | 0.170 |
Why?
|
| Child, Preschool | 8 | 2026 | 2075 | 0.170 |
Why?
|
| Cost Savings | 1 | 2021 | 60 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 2496 | 0.170 |
Why?
|
| Legionnaires' Disease | 1 | 2020 | 8 | 0.170 |
Why?
|
| Health Status | 1 | 2023 | 448 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 142 | 0.160 |
Why?
|
| Smokers | 2 | 2018 | 117 | 0.160 |
Why?
|
| Atrial Fibrillation | 2 | 2019 | 884 | 0.160 |
Why?
|
| Electrocardiography | 1 | 2023 | 555 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 1116 | 0.160 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 45 | 0.150 |
Why?
|
| Cost Sharing | 1 | 2019 | 15 | 0.150 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2020 | 69 | 0.150 |
Why?
|
| Exercise Test | 1 | 2021 | 257 | 0.150 |
Why?
|
| Mass Screening | 1 | 2025 | 700 | 0.150 |
Why?
|
| Amiodarone | 1 | 2019 | 22 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2024 | 731 | 0.150 |
Why?
|
| Rhode Island | 1 | 2019 | 110 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2012 | 805 | 0.150 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 183 | 0.150 |
Why?
|
| Massachusetts | 5 | 2016 | 2154 | 0.150 |
Why?
|
| Incidence | 3 | 2023 | 1432 | 0.150 |
Why?
|
| Child | 9 | 2026 | 4633 | 0.140 |
Why?
|
| Atrial Flutter | 1 | 2019 | 33 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 102 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2019 | 130 | 0.140 |
Why?
|
| Data Warehousing | 1 | 2018 | 7 | 0.140 |
Why?
|
| Cardiology Service, Hospital | 1 | 2018 | 17 | 0.140 |
Why?
|
| Patient Preference | 1 | 2018 | 87 | 0.130 |
Why?
|
| Examination Tables | 1 | 2017 | 1 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2020 | 535 | 0.130 |
Why?
|
| Health Surveys | 2 | 2023 | 319 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 161 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 355 | 0.130 |
Why?
|
| Nicotine | 1 | 2018 | 118 | 0.130 |
Why?
|
| Oregon | 1 | 2017 | 19 | 0.130 |
Why?
|
| Texas | 1 | 2017 | 60 | 0.130 |
Why?
|
| Evaluation Studies as Topic | 1 | 2017 | 105 | 0.130 |
Why?
|
| Sample Size | 1 | 2017 | 67 | 0.130 |
Why?
|
| Renal Colic | 1 | 2017 | 14 | 0.120 |
Why?
|
| Psychotic Disorders | 2 | 2021 | 150 | 0.120 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2016 | 6 | 0.120 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2016 | 11 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2016 | 69 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2019 | 318 | 0.120 |
Why?
|
| Resuscitation Orders | 1 | 2017 | 45 | 0.120 |
Why?
|
| Cancer Survivors | 1 | 2018 | 130 | 0.120 |
Why?
|
| Urology | 1 | 2017 | 46 | 0.120 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 60 | 0.120 |
Why?
|
| Internal Medicine | 1 | 2017 | 154 | 0.120 |
Why?
|
| Data Mining | 1 | 2016 | 38 | 0.120 |
Why?
|
| Boston | 1 | 2017 | 260 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2016 | 149 | 0.120 |
Why?
|
| Models, Economic | 2 | 2015 | 42 | 0.120 |
Why?
|
| Health Facility Size | 1 | 2015 | 16 | 0.120 |
Why?
|
| Fluoroquinolones | 1 | 2016 | 33 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2016 | 57 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 644 | 0.120 |
Why?
|
| Linear Models | 2 | 2017 | 405 | 0.120 |
Why?
|
| Diet Therapy | 1 | 2015 | 15 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 223 | 0.110 |
Why?
|
| Patient Care Bundles | 1 | 2015 | 11 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 294 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2017 | 296 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 94 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 146 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 248 | 0.110 |
Why?
|
| Drug Therapy, Combination | 4 | 2020 | 463 | 0.110 |
Why?
|
| Walking | 1 | 2017 | 247 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2016 | 309 | 0.110 |
Why?
|
| Gastroenterology | 1 | 2014 | 29 | 0.110 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 79 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2015 | 80 | 0.110 |
Why?
|
| Data Collection | 2 | 2015 | 384 | 0.110 |
Why?
|
| Weight Loss | 1 | 2017 | 275 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2016 | 224 | 0.100 |
Why?
|
| Ceftriaxone | 1 | 2014 | 20 | 0.100 |
Why?
|
| Hospital Information Systems | 1 | 2014 | 10 | 0.100 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2014 | 15 | 0.100 |
Why?
|
| Macrolides | 1 | 2014 | 38 | 0.100 |
Why?
|
| Treatment Failure | 3 | 2021 | 208 | 0.100 |
Why?
|
| Mothers | 1 | 2017 | 281 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2015 | 204 | 0.100 |
Why?
|
| Communication Barriers | 1 | 2014 | 71 | 0.100 |
Why?
|
| Patient Selection | 1 | 2016 | 484 | 0.100 |
Why?
|
| Wheelchairs | 1 | 2013 | 8 | 0.100 |
Why?
|
| Architectural Accessibility | 1 | 2013 | 4 | 0.100 |
Why?
|
| Moving and Lifting Patients | 1 | 2013 | 17 | 0.100 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2013 | 10 | 0.100 |
Why?
|
| England | 1 | 2013 | 28 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 66 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 220 | 0.090 |
Why?
|
| Counseling | 1 | 2015 | 376 | 0.090 |
Why?
|
| Delirium | 1 | 2013 | 55 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 72 | 0.090 |
Why?
|
| Organ Dysfunction Scores | 1 | 2012 | 24 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2012 | 14 | 0.090 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2012 | 13 | 0.090 |
Why?
|
| Protein C | 1 | 2012 | 26 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 808 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2013 | 183 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2012 | 46 | 0.090 |
Why?
|
| Decision Making | 2 | 2017 | 429 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2017 | 725 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2013 | 147 | 0.090 |
Why?
|
| Risk Adjustment | 1 | 2011 | 94 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2014 | 744 | 0.080 |
Why?
|
| American Medical Association | 1 | 2011 | 5 | 0.080 |
Why?
|
| Public Sector | 1 | 2010 | 16 | 0.080 |
Why?
|
| Ethics, Medical | 1 | 2011 | 40 | 0.080 |
Why?
|
| United Kingdom | 1 | 2010 | 86 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2012 | 192 | 0.080 |
Why?
|
| Confidentiality | 1 | 2010 | 58 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2011 | 152 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2011 | 111 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 159 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 309 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 489 | 0.080 |
Why?
|
| Perception | 2 | 2021 | 186 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 1662 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2024 | 3328 | 0.070 |
Why?
|
| Models, Biological | 1 | 2014 | 1193 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2015 | 802 | 0.060 |
Why?
|
| Hospitals, Pediatric | 2 | 2019 | 56 | 0.060 |
Why?
|
| Propensity Score | 2 | 2020 | 192 | 0.060 |
Why?
|
| Patient Dropouts | 1 | 2026 | 51 | 0.060 |
Why?
|
| Medication Errors | 1 | 2026 | 127 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2017 | 498 | 0.050 |
Why?
|
| Diagnosis-Related Groups | 2 | 2015 | 86 | 0.050 |
Why?
|
| Focus Groups | 1 | 2025 | 328 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2025 | 200 | 0.050 |
Why?
|
| Registries | 1 | 2026 | 933 | 0.040 |
Why?
|
| General Surgery | 1 | 2024 | 210 | 0.040 |
Why?
|
| Surgeons | 1 | 2024 | 191 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 345 | 0.040 |
Why?
|
| Legionella pneumophila | 1 | 2020 | 10 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 183 | 0.040 |
Why?
|
| Diagnostic Equipment | 1 | 2020 | 1 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 85 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 290 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 140 | 0.040 |
Why?
|
| Symptom Flare Up | 1 | 2020 | 15 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 746 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 67 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 108 | 0.040 |
Why?
|
| Personal Narratives as Topic | 1 | 2019 | 1 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 498 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 501 | 0.040 |
Why?
|
| Income | 1 | 2019 | 169 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 137 | 0.030 |
Why?
|
| American Hospital Association | 1 | 2017 | 3 | 0.030 |
Why?
|
| Minnesota | 1 | 2017 | 47 | 0.030 |
Why?
|
| Observation | 1 | 2017 | 30 | 0.030 |
Why?
|
| Physical Examination | 1 | 2017 | 109 | 0.030 |
Why?
|
| Insurance | 1 | 2017 | 18 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 40 | 0.030 |
Why?
|
| Nephrology | 1 | 2017 | 16 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 72 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 710 | 0.030 |
Why?
|
| Kidney Calculi | 1 | 2017 | 34 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 58 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 142 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 70 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 373 | 0.030 |
Why?
|
| Emergencies | 1 | 2016 | 124 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 77 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 78 | 0.030 |
Why?
|
| Cost Control | 1 | 2015 | 24 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 95 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 371 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 2015 | 122 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 182 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 197 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1233 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 491 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 208 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2015 | 190 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2017 | 195 | 0.030 |
Why?
|
| Bacteremia | 1 | 2015 | 91 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 175 | 0.030 |
Why?
|
| Pamphlets | 1 | 2013 | 17 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2013 | 14 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 756 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 464 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2016 | 226 | 0.020 |
Why?
|
| Health Literacy | 1 | 2013 | 95 | 0.020 |
Why?
|
| Child Health Services | 1 | 2013 | 68 | 0.020 |
Why?
|
| Comprehension | 1 | 2013 | 143 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 1277 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2013 | 210 | 0.020 |
Why?
|
| Stroke | 1 | 2021 | 1220 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 326 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 555 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 1437 | 0.020 |
Why?
|